Evidence map›Paper›PMID 40878399›Full record

ArticleJournal of gynecologic oncology2026

Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries.

Mikiko Asai-Sato, Masahiko Sakaguchi, Seiki Kanemura, Toshitaka Morishima, Kei Kawana, Yohei Miyagi, Kayoko Katayama

Abstract read
In one paragraph

Article in Journal of gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Mikiko Asai-SatoGynecology Section, St. Luke International Hospital's Branch Clinic MediLocus, Tokyo, Japan.ORCID 0000-0002-7811-947X
Masahiko SakaguchiUnit of Cancer Education, Kanagawa Cancer Center Research Institute, Yokohama, Japan.ORCID 0000-0001-5109-384X
Seiki KanemuraDivision of Cancer Epidemiology and Prevention, Miyagi Cancer Center Research Institute, Natori, Japan.ORCID 0000-0003-0454-0322
Toshitaka MorishimaCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.ORCID 0000-0002-0747-3287
Kei KawanaDepartment of Obstetrics and Gynecology, Nihon University, Tokyo, Japan.ORCID 0000-0003-1919-8830
Yohei MiyagiUnit of Cancer Education, Kanagawa Cancer Center Research Institute, Yokohama, Japan.ORCID 0000-0002-0056-7010
Kayoko KatayamaUnit of Cancer Education, Kanagawa Cancer Center Research Institute, Yokohama, Japan.ORCID 0000-0001-6237-5850

Funding

Pfizer Health Research FoundationSt. Luke's Health Science Research Fund
6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the incidence of subsequent primary cancer (SPC) among cervical cancer survivors in Japan.

methodsData from the cancer registries of Osaka, Kanagawa, and Miyagi prefectures were combined. The cohort included individuals diagnosed with invasive and in situ cervical cancer between 1980 and 2010, with the SPC incidence evaluated until 2015. The incidence and standardized incidence ratio (SIR) for different SPC sites were calculated. In addition, the association between SPC and radiotherapy was examined via competitive regression analysis.

resultsA total of 49,824 cervical cancer survivors were followed for up to 35 years, during which 4,507 (9.0%) of these survivors experienced SPC. Aside from the initial cancer, SPC was the most common cause of death among cervical cancer survivors. The most frequent SPC sites were the colorectal, breast, lung, and stomach, consistent with the frequency in the general population. A significant increase in the SIRs for bladder, lung, and colorectal cancers was observed (2.52, 1.63, and 1.44, respectively). Individuals who underwent radiotherapy had a higher risk of developing bladder cancer than those who did not, with a subdistribution hazard ratio of 2.28. The SIR for lung cancer significantly increased, particularly for the smoking-associated types, indicating the influence of smoking habits among survivors. Increased risk of specific SPCs was seen in both invasive and in situ cancer survivors.

conclusionCervical cancer survivors should be informed about the risks of SPCs and educated on the prevention methods. Our study provides valuable insights into specific actions SPC prevention.

Indexed as

Cancer SurvivorsNeoplasms, Second PrimaryUterine Cervical NeoplasmsAdultAgedCohort StudiesEast Asian PeopleFemaleHumansIncidenceJapanMiddle AgedRegistriesCancer SurvivorshipCervical CancerCohort StudyRegistriesSecond Primary Cancer

Identifiers

PMID40878399
PMCPMC12867657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.